Pyridoxal-5-phos Mdv recalls
The FDA has published 2 recalls involving Pyridoxal-5-phos Mdv since 2017. The latest was reported on 24 May 2017. Most were for sterility. Recalls usually affect specific lots, not every bottle on the market. Check the lot number on each recall page before acting.
Total recalls2since 2017
Last 12 months0reported
Class I00% of total
Ongoing0latest 24 May 2017
Recalls per month, last 24 months
click a bar for that monthSeverity split
Class I 0 0%Class II 2 100%Class III 0 0%
Why pyridoxal-5-phos mdv is recalled
Companies
By year
All pyridoxal-5-phos mdv recalls, newest first
2 total| Reported | Class | Recall | Company | Reason | Where |
|---|---|---|---|---|---|
| Drug | CLASS II | Pyridoxal-5-Phos Mdv 50MG/ML Inj, 50mg/mL recalled | Key Pharmacy and Compounding Center | Sterility | Nationwide |
| Drug | CLASS II | Pyridoxal-5-Phos Mdv 100MG/ML Inj, Injection, 100mg/mL recalled | Key Pharmacy and Compounding Center | Sterility | Nationwide |
Should you stop taking Pyridoxal-5-phos Mdv?
Not on your own. Most recalls affect specific lots from one manufacturer, and stopping a prescription suddenly can be riskier than the defect. Check your lot number and NDC against the recall, then call the pharmacy that dispensed it for a replacement.